Immix Biopharma IMMX
NASDAQ IMMX
$8.66 +0.31 (+3.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Immix Biopharma (IMMX) Other Non Operating Income (2021 - 2026)

Updated

Immix Biopharma (IMMX) reported Other Non Operating Income of -$22.02 million for Q4 2021.

Analysis

Immix Biopharma (IMMX) Other Non Operating Income (2021 - 2026) Analysis & Trends

For FY2021, Immix Biopharma posted Other Non Operating Income of -$22.76 million.

  • By year, Other Non Operating Income came in at -$575,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immix Biopharma 597.32 Mn 365.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.75 Bn
Mar 31, 2026 -23,665.00
Dec 31, 2025 -63.52 Bn
Sep 30, 2025 -2.57 Bn
Jun 30, 2025 49.57 Bn
Mar 31, 2025 16,519.00
Dec 31, 2024 -57.39 Bn
Sep 30, 2024 75.08 Bn
Jun 30, 2024 27.36 Bn
Mar 31, 2024 -45,052.00
Dec 31, 2023 40.29 Bn
Sep 30, 2023 -34.15 Bn
Jun 30, 2023 -1.67 Bn
Mar 31, 2023 -4,474.00
Dec 31, 2022 63.35 Bn
Sep 30, 2022 -40.39 Bn
Jun 30, 2022 -38.55 Bn
Mar 31, 2022 15,587.00
Dec 31, 2021 -22.11 Mn
Sep 30, 2021 -3,519.00
API Access

Immix Biopharma Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IMMX&period=max&api_key=YOUR_API_KEY